Tuesday, April 16, 2024
ISSN 2765-8767
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Home
  • Courses
  • About Us
  • Contact us
  • Support Us

Dr. Singer of the Cato Institute discusses trends in drug policy

Dr. Jeffrey Singer is a senior fellow at the Cato Institute and works in the Department of Health Policy Studies. He is a nationally recognized thought leader in health policy, particularly the harmful effects of drug prohibition.

He has written extensively about the importance of harm reduction and follows national and state policy closely.

The JAMA article cited during the podcast that questions the legitimacy of MME (Morphine Milligram Equivalents) is in the following link:

https://jamanetwork.com/journals/jama/article-abstract/358674

#prohibition #drugs #overdose #fentanyl #carfentanil #nitazene #xylazine

Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply

Your email address will not be published. Required fields are marked *

Videos

Opioid settlement payout tracker

Newsletter

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do

Start your Daily Remedy journey

Cultivate your knowledge of current healthcare events and ensure you receive the most accurate, insightful healthcare news and editorials.

*we hate spam as much as you do